Blog

Shilpa Gupta: Amazing to see our first patient on EV-302 still in CR after 3 years featured in our The Case Comprehensive Cancer Center Annual Report

Photo of Shilpa Gupta taken from X/Twitter

Apr 15, 2024, 11:15

Shilpa Gupta: Amazing to see our first patient on EV-302 still in CR after 3 years featured in our The Case Comprehensive Cancer Center Annual Report

Shilpa Gupta, Director of Genitourinary Oncology at Cleveland Clinic, shared on X:

“Amazing to see our first patient on EV-302 (EV+P arm) still in CR after 3 years featured in our The Case Comprehensive Cancer Center Annual Report EV+P sets the bar high for efficacy & QoL. Thanks to our patients & team at Cleveland Clinic for making this study a success. ”

Read further.
Source: Shilpa Gupta/X

Annual Report cancer Case Comprehensive Cancer Center Cleveland Clinic clinical trial efficacy EV-302 EVP OncoDaily Oncology patient success quality of life team effort.

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage